SI-BONE ROIC at -8.99% Versus 8.22% WACC, Trails Peers
SI-BONE’s ROIC of -8.99% falls well below its 8.22% WACC, producing an ROIC/WACC ratio of -1.09 and indicating value destruction. Peers Axonics and OrthoPediatrics also post negative ROICs, while Tactile Systems nears breakeven with a 7.93% ROIC against an 8.04% WACC.
1. SI-BONE’s Capital Efficiency Metrics
SI-BONE’s latest figures show a Return on Invested Capital of -8.99% and a Weighted Average Cost of Capital of 8.22%, resulting in an ROIC/WACC ratio of -1.09 and indicating the company currently loses $1.09 for every dollar invested.
2. Peer Comparison Highlights Industry Challenges
Among its medical device peers, Axonics reports a -2.68% ROIC and OrthoPediatrics records -6.41%, both metrics pointing to ongoing value destruction and industry-wide capital inefficiencies.
3. Tactile Systems’s Near-Break-Even Return
Tactile Systems Technology stands out with a 7.93% ROIC against an 8.04% WACC, yielding an ROIC/WACC ratio of 0.99 and signaling near breakeven performance relative to the cost of capital.